Ítem
Solo Metadatos
Reaching a personalized medicine era: The dream of the drug market
Título de la revista
Autores
Barajas-Gamboa J.S.
Tarquino P.F.
Pedraza J.E.
Gonzalez-Nuñez D.
Fecha
2016
Directores
ISSN de la revista
Título del volumen
Editor
JMN Medical Education Ltd
Buscar en:
Métricas alternativas
Resumen
Abstract
Personalized medicine, the study of the influence of a patient’s genetic makeup on their disease susceptibility, prognosis, or treatment response (efficacy and safety), is actually in the spotlight. This field is expected to allow us to have effective and safe medication to targeted patients with appropriate genotypes. © 2016, JMN Medical Education Ltd. All rights reserved.
Palabras clave
Keywords
Estrogen receptor , Breast cancer , Castration resistant prostate cancer , Cdk12 gene , Disease predisposition , Dna repair , Drug efficacy , Drug industry , Drug marketing , Drug safety , Editorial , Fanca gene , Genetic disorder , Genetics , Genomics , Genotype , Health care planning , Health care system , Hormonal therapy , Human , Medical research , Personalized medicine , Pharmacogenomics , Practice guideline , Prepregnancy care , Prognosis , Rad51b gene , Science , Single nucleotide polymorphism , Treatment outcome , Treatment response , Tumor suppressor gene , Clinical outcomes , Drug response , Human genomics , Personalized medicine , Pharmacogenetics
